跳至主要内容
临床试验/CTRI/2022/10/046474
CTRI/2022/10/046474进行中(未招募)未知

To study the effectiveness and safety of prochlorperazine in patients suffering from vestibular migraine

Abbott Healthcare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Male and female patients in the age group of 18-65 years
  • 2.Patients diagnosed of vestibular migraine based on to ICHD-3 criteria9
  • 3.Patient who has read the informed consent form, has understood the relevant aspects of the clinical study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the clinical study and the performance of any procedure

排除标准

  • 1.Patients on prochlorperazine or any other anti-vertigo therapy drugs in the past 30 days
  • 2.Patients with history of psychiatric illness in the past 6 months
  • 3.Patients on anti-psychotic or anti-depressant medication in the past 6 months
  • 4.Patients with history of cardiovascular, kidney or liver disorder
  • 5.Patients with suspected or established subcortical brain damage, with or without hypothalamic damage
  • 6.Females who are pregnant/planning to become pregnant/not ready to use contraceptive measures or are lactating

研究者

相似试验